Dr. James Raybourn, M.D
NPI: 1871736595
Total Payments
$23,089
2024 Payments
$16,532
Companies
42
Transactions
280
Medicare Patients
19,395
Medicare Billing
$1.8M
Payment Breakdown by Category
Other$15,300 (66.3%)
Food & Beverage$6,385 (27.7%)
Travel$1,238 (5.4%)
Education$165.94 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Long term medical supply or device loan | $15,300 | 1 | 66.3% |
| Food and Beverage | $6,385 | 264 | 27.7% |
| Travel and Lodging | $1,238 | 8 | 5.4% |
| Education | $165.94 | 6 | 0.7% |
| Unspecified | $0 | 1 | 0.0% |
Payments by Type
General
$23,089
279 transactions
Ownership
$0
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Central Indiana URS Consumables, LLC | $15,300 | 2 | $0 (2024) |
| Intuitive Surgical, Inc. | $2,200 | 15 | $0 (2018) |
| Bayer Healthcare Pharmaceuticals Inc. | $689.08 | 23 | $0 (2024) |
| Dendreon Pharmaceuticals LLC | $681.58 | 19 | $0 (2024) |
| Janssen Biotech, Inc. | $573.09 | 32 | $0 (2024) |
| Astellas Pharma US Inc | $483.98 | 35 | $0 (2024) |
| PFIZER INC. | $377.60 | 24 | $0 (2024) |
| ABBVIE INC. | $277.36 | 17 | $0 (2024) |
| GENZYME CORPORATION | $252.06 | 12 | $0 (2023) |
| Valeant Pharmaceuticals North America LLC | $186.27 | 6 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $16,532 | 57 | Central Indiana URS Consumables, LLC ($15,300) |
| 2023 | $1,005 | 41 | Dendreon Pharmaceuticals LLC ($217.50) |
| 2022 | $527.88 | 21 | Bayer HealthCare Pharmaceuticals Inc. ($151.27) |
| 2021 | $280.92 | 13 | Janssen Biotech, Inc. ($126.67) |
| 2020 | $456.33 | 19 | Bayer HealthCare Pharmaceuticals Inc. ($147.84) |
| 2019 | $594.17 | 33 | Bayer HealthCare Pharmaceuticals Inc. ($137.41) |
| 2018 | $2,602 | 50 | Intuitive Surgical, Inc. ($2,129) |
| 2017 | $1,090 | 46 | Dendreon Pharmaceuticals LLC ($250.72) |
All Payment Transactions
280 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/21/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $24.79 | General |
| Category: NEUROLOGY | ||||||
| 12/16/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $28.77 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 12/13/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $28.14 | General |
| Category: Oncology | ||||||
| 12/09/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $28.56 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 12/06/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $14.14 | General |
| Category: Oncology | ||||||
| 12/03/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $28.46 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 11/26/2024 | Central Indiana URS Consumables, LLC | Dornier MedTech (Medical Supply), CVAC Aspiration System, Dornier MedTech | Long term medical supply or device loan | Stock option | $15,300.00 | General |
| Category: Ureteroscopy | ||||||
| 11/25/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $23.21 | General |
| Category: Oncology | ||||||
| 11/08/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: Oncology | ||||||
| 11/05/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $22.16 | General |
| Category: UROTHELIAL CANCER | ||||||
| 11/01/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | YONSA (Drug) | Food and Beverage | In-kind items and services | $20.40 | General |
| Category: Oncology | ||||||
| 10/29/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $24.06 | General |
| Category: Oncology | ||||||
| 10/28/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: UROTHELIAL CANCER | ||||||
| 10/11/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $26.25 | General |
| Category: Oncology | ||||||
| 10/07/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $22.55 | General |
| Category: Oncology | ||||||
| 10/01/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $23.78 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 09/24/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: ONCOLOGY | ||||||
| 09/13/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $22.33 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 09/09/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $32.35 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/09/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $30.02 | General |
| Category: Oncology | ||||||
| 09/06/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | YONSA (Drug) | Food and Beverage | In-kind items and services | $21.09 | General |
| Category: Oncology | ||||||
| 09/04/2024 | Laborie Medical Technologies Corp. | Optilume BPH Drug Coated Balloon Catheter (Device) | Food and Beverage | Cash or cash equivalent | $48.82 | General |
| Category: Urology | ||||||
| 09/03/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $34.57 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 08/26/2024 | Tolmar, Inc. | ELIGARD (Drug), JATENZO | Food and Beverage | Cash or cash equivalent | $30.01 | General |
| Category: ONCOLOGY | ||||||
| 08/19/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 47 | 4,284 | 14,135 | $1.3M | $386,648 |
| 2022 | 52 | 4,227 | 18,299 | $1.4M | $427,579 |
| 2021 | 56 | 5,466 | 25,090 | $1.9M | $565,457 |
| 2020 | 58 | 5,418 | 16,761 | $1.7M | $449,036 |
Total Patients
19,395
Total Services
74,285
Medicare Billing
$1.8M
Procedure Codes
213
All Medicare Procedures & Services
213 procedure records from CMS Medicare Utilization — Page 1 of 9
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 35 | 8,100 | $243,000 | $147,768 | 60.8% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 62 | 483 | $340,032 | $62,388 | 18.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 389 | 631 | $162,167 | $52,871 | 32.6% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 73 | 412 | $49,028 | $17,468 | 35.6% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 673 | 745 | $56,620 | $13,409 | 23.7% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 59 | 78 | $60,684 | $12,334 | 20.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 55 | 58 | $20,126 | $7,308 | 36.3% |
| 99426 | Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 30 | 156 | $32,604 | $7,059 | 21.7% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 177 | 209 | $22,154 | $5,286 | 23.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 90 | 96 | $16,704 | $5,160 | 30.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 69 | 69 | $17,733 | $5,046 | 28.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 66 | 85 | $14,875 | $5,016 | 33.7% |
| 87086 | Bacterial colony count, urine | Office | 2023 | 498 | 534 | $17,622 | $4,224 | 24.0% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 64 | 155 | $14,105 | $3,386 | 24.0% |
| 87186 | Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution | Office | 2023 | 312 | 370 | $13,320 | $3,137 | 23.6% |
| 87088 | Bacterial urine culture | Office | 2023 | 317 | 390 | $13,260 | $3,093 | 23.3% |
| 88112 | Cell examination of specimen, selective cellular enhancement technique | Office | 2023 | 79 | 79 | $16,195 | $2,555 | 15.8% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 28 | 68 | $9,248 | $2,385 | 25.8% |
| 82670 | Measurement of total estradiol (hormone) | Office | 2023 | 74 | 86 | $9,890 | $2,355 | 23.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 22 | 22 | $8,668 | $2,349 | 27.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 18 | 18 | $8,838 | $2,330 | 26.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 23 | 23 | $7,613 | $2,226 | 29.2% |
| 84270 | Sex hormone binding globulin (protein) level | Office | 2023 | 87 | 99 | $8,811 | $2,109 | 23.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 11 | 11 | $5,445 | $1,736 | 31.9% |
| 84154 | Psa (prostate specific antigen) measurement, free | Office | 2023 | 92 | 96 | $7,296 | $1,730 | 23.7% |
About Dr. James Raybourn, M.D
Dr. James Raybourn, M.D is a Student in an Organized Health Care Education/Training Program healthcare provider based in Greenwood, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/10/2009. The National Provider Identifier (NPI) number assigned to this provider is 1871736595.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Raybourn, M.D has received a total of $23,089 in payments from pharmaceutical and medical device companies, with $16,532 received in 2024. These payments were reported across 280 transactions from 42 companies. The most common payment nature is "Long term medical supply or device loan" ($15,300).
As a Medicare-enrolled provider, Raybourn has provided services to 19,395 Medicare beneficiaries, totaling 74,285 services with total Medicare billing of $1.8M. Data is available for 4 years (2020–2023), covering 213 distinct procedure/service records.
Ad
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Urology
- Location Greenwood, IN
- Active Since 04/10/2009
- Last Updated 01/19/2024
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1871736595
Products in Payments
- Dornier MedTech (Medical Supply) $15,300
- Da Vinci Surgical System (Device) $2,200
- PROVENGE (Drug) $867.85
- ERLEADA (Drug) $412.22
- XTANDI (Drug) $389.80
- Xofigo (Drug) $351.60
- Nubeqa (Drug) $337.48
- ORGOVYX (Drug) $254.98
- JEVTANA (Drug) $235.19
- Xtandi (Drug) $153.10
- YONSA (Drug) $148.20
- ELIGARD (Drug) $147.58
- Androgel (Drug) $142.91
- Myrbetriq (Drug) $128.60
- LYNPARZA (Drug) $127.64
- CAMCEVI (Drug) $118.52
- Erleada (Drug) $116.72
- ZALTRAP (Drug) $99.00
- MYRBETRIQ (Drug) $96.66
- JELMYTO (Drug) $95.10
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Greenwood
Dr. Weston Kitley, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $16,606
Student in an Organized Health Care Education/Training Program $16,606
Santosh Swaminathan
Student in an Organized Health Care Education/Training Program — Payments: $4,997
Student in an Organized Health Care Education/Training Program $4,997
Ryan Sanderson, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $3,898
Student in an Organized Health Care Education/Training Program $3,898
Minesh Rajkotia, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $3,438
Student in an Organized Health Care Education/Training Program $3,438
Dr. Emily Zarse, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $3,243
Student in an Organized Health Care Education/Training Program $3,243
Daniel Saha, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $2,041
Student in an Organized Health Care Education/Training Program $2,041